Quality of life and economic evaluation in SLE clinical trials

C Gordon; A E Clarke

doi:10.1191/096120399680411344

Quality of life and economic evaluation in SLE clinical trials

Lupus. 1999;8(8):645-54. doi: 10.1191/096120399680411344.

Authors

C Gordon¹, A E Clarke

Affiliation

¹ Department of Rheumatology, Division of Immunity and Infection, Medical School, University of Birmingham, UK.

PMID: 10568902
DOI: 10.1191/096120399680411344

Abstract

Outcome in SLE patients should include assessment of disease activity and chronic damage and also measurement of health-related quality of life and the economic impact of the disease. This paper reviews the methods available for doing this and the results of existing studies in SLE patients.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anxiety
Canada
Clinical Trials as Topic / methods*
Costs and Cost Analysis
Depression
Europe
Fatigue
Health Status
Health Status Indicators
Humans
Lupus Erythematosus, Systemic / economics
Lupus Erythematosus, Systemic / physiopathology
Lupus Erythematosus, Systemic / psychology
Lupus Erythematosus, Systemic / therapy*
Quality of Life*
Surveys and Questionnaires
Treatment Outcome